RxDoctor Payments Data

Celeste Rains, DO

Family Medicine · Oakley, KSNPI 1013901958

Payments from drug & device makers

$1,105in general payments, 2019–2025

Across 66 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$341
  • Lilly USA, LLC$145
  • AbbVie$137
  • Astellas Pharma US Inc$135
  • AstraZeneca$81
  • Novo Nordisk$64
  • plus $204 from 5 others

What the payments were for

  • Food & beverage$1,00591%
  • Education$1009%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,105 in reported general payments places this provider in the 60th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$20,889
Medicare patients
138
Services billed
815

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban146$94,451
TrulicityDulaglutide65$62,108
MounjaroTirzepatide56$56,493
FarxigaDapagliflozin Propanediol93$45,074
JanuviaSitagliptin Phosphate65$33,604
MyrbetriqMirabegron58$31,376
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog26$12,871
JardianceEmpagliflozin19$11,582
XareltoRivaroxaban13$10,267
Fiasp FlextouchInsulin Aspart (Niacinamide)13$7,085
GemtesaVibegron16$6,587
Potassium Chloride200$5,165
ArexvyRsvpref3 Antigen/As01e/Pf15$4,778
Levothyroxine Sodium349$4,655
ShingrixVaricella-Zoster Ge/As01b/Pf20$4,495

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$145$118,601121 claims
PfizerEliquis$51$94,451146 claims
AstraZenecaFarxiga$81$45,07493 claims
MerckJanuvia$13$33,60465 claims
Astellas Pharma US IncMyrbetriq$135$31,37658 claims
AbbVieSynthroid$137$2,32836 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Oakley

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →